#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer recurrent Alport's syndrome Prophylaxis against transplant rejection Plasma cell myeloma refractory Arginase deficiency Ductal adenocarcinoma of pancreas Hereditary optic atrophy Cutaneous T-cell lymphoma Blastic plasmacytoid dendritic cell neoplasia Lennox-Gastaut syndrome Oesophageal squamous cell carcinoma stage II Fibrosarcoma metastatic Fibrous dysplasia of bone Sarcoidosis Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Progressive supranuclear palsy – Diagnostics Hairy cell leukaemia – Trials in Disease Haemophagocytic lymphohistiocytosis – Life with Disease Pituitary-dependent Cushing’s syndrome – Basic Information Metachromatic leukodystrophy – Treatment Indolent systemic mastocytosis – Basic Information Phenylketonuria – Diagnostics Pulmonary fibrosis – Diagnostics Haemolytic uraemic syndrome Fragile X syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bay 2927088 Levocarnitine Tradipitant Savolitinib Fentanyl Brimonidine Tartrate Eptinezumab Ritonavir Nortriptyline Sirexatamab Belantamab Mafodotin Radium Ra 223 Dichloride Evencaleucel Erythromycin Lactobionate Levothyroxine 64CU-PSMA I&T Fipaxalparant Ipatasertib GSKVX000000017986 Tiragolumab More therapies…

    Learn about Your Condition

    Arteriovenous malformation Marginal zone lymphoma Staphylococcal bacteraemia Developmental hip dysplasia Hypersomnia Femur fracture Hypervolaemia Cardiogenic shock Colitis Pathogen resistance Peritoneal dialysis Head and neck cancer stage III Intellectual disability Cutibacterium acnes infection Nodular melanoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypertension

  • Study of Allopurinol to Reduce Cardiovascular Events in High-Risk Patients with Heart Disease and Long-COVID Syndrome

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transient ischaemic attack
    • Ischaemic stroke
    • Diabetes mellitus
    Investigated Drugs:
    • Allopurinol
    Poland

  • Study on the Effect of Aprepitant on Aldosterone Levels in Patients with Obstructive Sleep Apnea and High Blood Pressure

    Recruiting

    3 1 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    • Hypertension
    Investigated Drugs:
    • Lactose Monohydrate
    France

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    • Chronic kidney disease
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study Comparing Eplerenone and Irbesartan for Lowering Blood Pressure in Obese Patients with Hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Amlodipine
    • Eplerenone
    • Indapamide
    Greece

  • A study to evaluate the effect of baxdrostat and dapagliflozin in reducing protein in the urine for patients with chronic kidney disease and high blood pressure

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Baxdrostat
    • Dapagliflozin
    Bulgaria Spain

  • Evaluation of the Drug‑Drug Interaction Between Ramipril and Indapamide in Healthy Volunteers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Hypertension
    Investigated Drugs:
    • Indapamide
    • Ramipril
    Czechia
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!